MD Anderson’s Keeling Center Open House set for April 21
The University of Texas MD Anderson Cancer Center’s Michale E. Keeling Center for Comparative Medicine and Research will open its doors to the community from 3 p.m. to 7 p.m. Friday, April 21.
“We welcome our Central Texas neighbors to visit and learn about the important research that we do at the Keeling Center to improve medical care by increasing our understanding of human disease,” said Christian Abee, D.V.M., director of the...
Local restaurants and businesses bring prom to MD Anderson
The University of Texas MD Anderson Children’s Cancer Hospital joins Houston restaurants and businesses to host its second annual Prom Party...
Jim Allison named one of TIME’s 100 most influential people
The University of Texas MD Anderson Cancer Center Chair of Immunology Jim Allison, Ph.D., whose pivotal insight to attack cancer by treating...
Pathologic complete response to neoadjuvant therapy in certain breast cancer patients predicts low risk for local metastases
Select breast cancer patients who achieved pathologic complete response (pCR) after chemotherapy may be able to avoid follow-up breast and lymph node, or axillary, surgery, according to new findings from researchers at The University of Texas MD Anderson Cancer Center. The study, published today in JAMA Surgery, identifies the exceptional responders who are at lowest risk for local metastases and thereby are candidates for less invasive...
MD Anderson and Lion Biotechnologies announce strategic alliance to conduct clinical trials of TILs in multiple solid tumors
The University of Texas MD Anderson Cancer Center and Lion Biotechnologies, Inc., a biotechnology company developing novel cancer immunotherapies...
Making Cancer History®: Free seminar returns to Midland
The University of Texas MD Anderson Cancer Center brings its signature Making Cancer History® Seminar to Midland, for the second time, 11:...
MD Anderson, Oncora Medical team up to fight cancer with precision medicine alliance
Oncora Medical, a precision radiation oncology software company, and The University of Texas MD Anderson Cancer Center, today announced a...
Stand Up to Cancer innovation grant funds MD Anderson microbiome study
An Innovative Research Grant from Stand Up to Cancer will help a University of Texas MD Anderson Cancer Center physician scientist and her...